{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:53:44Z","timestamp":1770980024988,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1124\/pr.108.00372","type":"journal-article","created":{"date-parts":[[2008,7,9]],"date-time":"2008-07-09T03:51:47Z","timestamp":1215575507000},"page":"143-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["International Union of Pharmacology. LXIX. Status of the Calcitonin Gene-Related Peptide Subtype 2 Receptor"],"prefix":"10.1016","volume":"60","author":[{"given":"Debbie L.","family":"Hay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Poyner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remi","family":"Quirion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/pr.108.00372_bib1","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.peptides.2005.11.014","article-title":"Pharmacology of the human CGRP1 receptor in Cos 7 cells","volume":"27","author":"Bailey","year":"2006","journal-title":"Peptides"},{"key":"10.1124\/pr.108.00372_bib2","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1124\/jpet.107.133660","article-title":"Functional antagonism between endogenous neuropeptide Y and calcitonin gene-related peptide in mesenteric resistance arteries","volume":"324","author":"De Mey","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.108.00372_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3565(25)12587-1","article-title":"hCGRP8\u201337, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery","volume":"254","author":"Dennis","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.108.00372_bib4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0022-3565(25)20868-0","article-title":"Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues: evidence for receptor multiplicity","volume":"251","author":"Dennis","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.108.00372_bib5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.bjp.0707134","article-title":"Inhibitory effect of BIBN4096BS, CGRP(8\u201337), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery","volume":"150","author":"Edvinsson","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.108.00372_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.lfs.2006.01.003","article-title":"Characterisation of CGRP receptors in the human isolated middle meningeal artery","volume":"79","author":"Gupta","year":"2006","journal-title":"Life Sci"},{"key":"10.1124\/pr.108.00372_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2005.11.020","article-title":"Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity","volume":"530","author":"Gupta","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.108.00372_bib8","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1124\/mol.104.008615","article-title":"Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes","volume":"67","author":"Hay","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.108.00372_bib9","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1124\/mol.106.027953","volume":"70","author":"Hay","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.108.00372_bib10","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.peptides.2004.06.007","article-title":"The pharmacology of CGRP-responsive receptors in cultured and transfected cells","volume":"25","author":"Hay","year":"2004","journal-title":"Peptides"},{"key":"10.1124\/pr.108.00372_bib11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.bjp.0705472","article-title":"CL\/RAMP2 and CL\/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22\u201352, CGRP8\u201337 and BIBN4096BS","volume":"140","author":"Hay","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.108.00372_bib12","doi-asserted-by":"crossref","first-page":"C811","DOI":"10.1152\/ajpcell.00504.2004","article-title":"Immature osteoblastic MG63 cells possess two calcitonin gene-related peptide receptor subtypes that respond differently to [Cys(Acm)2,7] calcitonin gene-related peptide and CGRP8\u201337","volume":"289","author":"Kawase","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/pr.108.00372_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/mol.65.1.207","article-title":"Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins","volume":"65","author":"Kuwasako","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.108.00372_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"10.1124\/pr.108.00372_bib15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0028-3908(02)00008-4","article-title":"Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment","volume":"42","author":"Moreno","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.108.00372_bib16","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bcp.2005.01.008","article-title":"Cys2,7Et\u03b1CGRP is a potent agonist for CGRP1 receptors in SK-N-MC cells","volume":"69","author":"Nodin","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.108.00372_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pr.54.2.233","article-title":"International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors","volume":"54","author":"Poyner","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pr.108.00372_bib18","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.bjp.0705967","article-title":"Noncompetitive antagonism of BIBN4096BS on CGRP-induced responses in human subcutaneous arteries","volume":"143","author":"Sheykhzade","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.108.00372_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.regpep.2003.11.006","article-title":"Effects of \u03b1 calcitonin gene-related peptide in human bronchial smooth muscle and pulmonary artery","volume":"118","author":"Springer","year":"2004","journal-title":"Regul Pept"},{"key":"10.1124\/pr.108.00372_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/sj.bjp.0706750","article-title":"Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture","volume":"148","author":"Takhshid","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.108.00372_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00210-005-1064-4","article-title":"BIBN4096BS and CGRP8\u201337 antagonize the relaxant effects of \u03b1-CGRP more than those of \u03b2-CGRP in human extracranial arteries","volume":"371","author":"Verheggen","year":"2005","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/pr.108.00372_bib22","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0022-3565(24)38288-6","article-title":"Limitations in using peptide drugs to characterize calcitonin gene-related peptide receptors","volume":"289","author":"Waugh","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.108.00372_bib23","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1124\/mol.107.042283","article-title":"Pharmacological and kinetic characterization of adrenomedullin 1 and calcitonin gene-related peptide 1 receptor reporter cell lines","volume":"73","author":"Wunder","year":"2008","journal-title":"Mol Pharmacol"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003169972403597X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003169972403597X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pr.108.00372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T11:14:58Z","timestamp":1739877298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003169972403597X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S003169972403597X"],"URL":"https:\/\/doi.org\/10.1124\/pr.108.00372","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International Union of Pharmacology. LXIX. Status of the Calcitonin Gene-Related Peptide Subtype 2 Receptor","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pr.108.00372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}